| New |
| Code |
Description |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
| J1741 |
Injection, ibuprofen, 100 mg |
| J1744 |
Injection, icatibant, 1 mg |
| J7178 |
Injection, human fibrinogen concentrate, 1 mg |
| G9818 |
Documentation of sexual activity |
| G9822 |
Women who had an endometrial ablation procedure during the year prior to the index date (exclusive of the index date) |
| G9899 |
Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed |
| G9900 |
Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results were not documented and reviewed, reason not otherwise specified |
| G9911 |
Clinically node negative (t1n0m0 or t2n0m0) invasive breast cancer before or after neoadjuvant systemic therapy |
| G9962 |
Embolization endpoints are documented separately for each embolized vessel and ovarian artery angiography or embolization performed in the presence of variant uterine artery anatomy |
| G9963 |
Embolization endpoints are not documented separately for each embolized vessel or ovarian artery angiography or embolization not performed in the presence of variant uterine artery anatomy |
| J1726 |
Injection, hydroxyprogesterone caproate, (makena), 10 mg |
| J1729 |
Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg |
| J7296 |
Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg |
